Showing results (41-50 of 85) with videos related to
Sort By:
Pageof 9
Pediatrics|August 1, 1989
Enteric adenovirus infection and childhood diarrhea: an epidemiologic study in three clinical settingsK L Kotloff, G A Losonsky, J G Morris, et al.Journal of Clinical Microbiology|October 4, 2000
Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study GroupP Baron, J Bremer, S S Wasserman, et al.Infection and Immunity|May 12, 2001
Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infectionK L Kotloff, M B Sztein, S S Wasserman, et al.Infection and Immunity|January 1, 1996
Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to choleraG A Losonsky, J Yunyongying, V Lim, et al.The Journal of Infectious Diseases|December 1, 1994
Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhiM B Sztein, S S Wasserman, C O Tacket, et al.Proceedings of the National Academy of Sciences of the United States of America|June 15, 1991
Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctionsA Fasano, B Baudry, D W Pumplin, et al.Infection and Immunity|June 1, 1990
Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonneiL Van de Verg, D A Herrington, J R Murphy, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1995
Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen OC O Tacket, G Losonsky, J P Nataro, et al.Lancet (London, England)|May 30, 1998
Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimensR Lagos, M T Valenzuela, O S Levine, et al.Infection and Immunity|February 13, 2001
Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adultsK L Kotloff, S S Wasserman, G A Losonsky, et al.Pageof 9